Proventil HFA

Proventil HFA is an environmentally friendly inhaler that contains albuterol. It can be used to prevent or treat bronchospasms that occur in people with asthma, chronic bronchitis, or emphysema. Proventil HFA causes the muscles around airways to relax, which opens up the airways. Some side effects that may occur when using this inhaler include upper respiratory tract infections, nausea, and vomiting.

 

What Is Proventil HFA?

Proventil® HFA (albuterol inhaler) is a prescription medication that is used to prevent or treat bronchospasms. Bronchospasms are most common in people with asthma but can also occur in people with chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. Proventil HFA is also approved to prevent exercise-induced asthma attacks.
 
Unlike older inhalers, Proventil HFA is an environmentally friendly albuterol inhaler.
 
(Click Proventil HFA Uses for more information on what Proventil HFA is used for, including possible off-label uses of the medication.)
 

Who Makes Proventil HFA?

Proventil HFA is made by the Schering-Plough Corporation.
 

How Does Proventil HFA Work?

Normally air moves easily into and out of the lungs through a network of airways. But, during an asthma attack, the muscles around these airways tighten. This narrows the airways and makes it harder to breathe. This is called bronchospasm.
 
Proventil HFA is part of a class of drugs called beta-adrenergic receptor agonists, or beta agonists for short. Beta agonists stimulate beta receptors in the body, including those on the muscles around airways. This stimulation causes the muscles to relax, which opens up the airways and allows more air to get into and through the lungs.
 
Proventil HFA also has some effects on decreasing the activity of mast cells in the lungs, which play an important role in inflammation and allergic reactions.
 
(Proventil HFA Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;